摘要：

Patient-derived iPS cell lines could be good models of the rare congenital disorder Leopard syndrome, which is characterized by hypertrophic cardiomyopathy caused by protein tyrosine phosphatase non-receptor type 11 (PTPN11) mutations. Further details on the research, next steps and licensing status are discussed in the article.

展开